- Report
- July 2025
- 196 Pages
Global
From €5140EUR$5,850USD£4,434GBP
- Report
- July 2025
- 474 Pages
Global
From €5140EUR$5,850USD£4,434GBP
- Report
- July 2025
- 413 Pages
Global
From €5140EUR$5,850USD£4,434GBP
- Report
- November 2024
- 183 Pages
Global
From €3361EUR$3,825USD£2,899GBP
€3954EUR$4,500USD£3,411GBP
- Report
- July 2024
- 185 Pages
Global
From €3361EUR$3,825USD£2,899GBP
€3954EUR$4,500USD£3,411GBP
- Report
- January 2025
- 185 Pages
Global
From €3361EUR$3,825USD£2,899GBP
€3954EUR$4,500USD£3,411GBP
- Report
- December 2024
- 200 Pages
Global
From €3295EUR$3,750USD£2,842GBP
- Report
- May 2025
- 154 Pages
Global
From €4174EUR$4,750USD£3,600GBP
- Report
- May 2025
- 115 Pages
Global
From €4174EUR$4,750USD£3,600GBP
- Report
- July 2024
- 120 Pages
Global
From €4174EUR$4,750USD£3,600GBP
- Report
- January 2025
- 180 Pages
Global
From €3361EUR$3,825USD£2,899GBP
€3954EUR$4,500USD£3,411GBP
- Report
- December 2024
- 200 Pages
Global
From €3295EUR$3,750USD£2,842GBP
- Report
- October 2024
- 200 Pages
Global
From €3295EUR$3,750USD£2,842GBP
- Report
- October 2024
- 200 Pages
Global
From €3295EUR$3,750USD£2,842GBP
- Report
- March 2025
- 150 Pages
Global
From €2856EUR$3,250USD£2,463GBP
€4262EUR$4,850USD£3,676GBP
- Report
- March 2025
- 150 Pages
Global
From €2856EUR$3,250USD£2,463GBP
€4262EUR$4,850USD£3,676GBP
- Report
- August 2024
- 150 Pages
Global
From €2856EUR$3,250USD£2,463GBP
€4262EUR$4,850USD£3,676GBP
- Report
- December 2024
- 146 Pages
Global
From €2777EUR$3,160USD£2,395GBP
€3471EUR$3,950USD£2,994GBP
- Report
- June 2025
- 400 Pages
Global
From €4349EUR$4,949USD£3,751GBP
- Report
- October 2024
- 200 Pages
Global
From €4349EUR$4,949USD£3,751GBP

A diagnostic biomarker is a biological molecule or gene that is used to identify a particular disease or condition. It is used to diagnose, monitor, and predict the progression of a disease or condition. Diagnostic biomarkers are used to detect the presence of a disease or condition, to determine the severity of the disease or condition, and to monitor the effectiveness of treatments. Diagnostic biomarkers are used in a variety of medical fields, including oncology, neurology, cardiology, and infectious diseases.
Diagnostic biomarkers are typically identified through a variety of methods, including genetic sequencing, proteomics, and metabolomics. These methods allow for the identification of biomarkers that are specific to a particular disease or condition.
The diagnostic biomarker market is a rapidly growing field, with many companies developing and marketing diagnostic biomarkers. Companies in this market include Illumina, Thermo Fisher Scientific, Qiagen, Roche, and Agilent Technologies. Show Less Read more